Publications by authors named "Koen Van Acker"

Claim this Profile
A
A fluorescence-based high-throughput screening assay to identify HIV-1 inhibitors.
Peggy Geluykens, Koen Van Acker, Johan Vingerhoets, Christel Van den Eynde, Marnix Van Loock

Methods Mol Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homogeneous time-resolved fluorescence assay to identify inhibitors of HIV-1 fusion.
Liesbet Smeulders, Lieve Bunkens, Inge Vereycken, Koen Van Acker, Pascale Holemans

Methods Mol Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An automated time-of-drug-addition assay to routinely determine the mode of action of HIV-1 inhibitors.
Marnix Van Loock, Christel Van den Eynde, John Hansen, Peggy Geluykens, Tania Ivens, Koen Van Acker

Assay Drug Dev Technol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCV.
Bertrand Van Schoubroeck, Koen Van Acker, Géry Dams, Dirk Jochmans, Reginald Clayton

Methods Mol Biol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A time-resolved fluorescence assay to identify small-molecule inhibitors of HIV-1 fusion.
Géry Dams, Koen Van Acker, Emmanuel Gustin, Inge Vereycken, Lieve Bunkens

J Biomol Screen· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus.
Tania Ivens, Christel Van den Eynde, Koen Van Acker, Erik Nijs, Géry Dams

J Virol Methods· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis